SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emcure Pharmaceuticals informs about incorporation of WOS

04 Jul 2025 Evaluate
With reference to its disclosure dated June 21, 2025 (copy attached), pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), related to proposed incorporation of a wholly-owned subsidiary (WoS) by the name ‘Emcure Wellness’ in Pune, Maharashtra, India, Emcure Pharmaceuticals has informed that as per the approval of Registrar of Companies, a WoS named ‘Emcure Wellness’ is incorporated on July, 03, 2025. All the particulars mentioned in the disclosure dated June 21, 2025, remains the same.

The above information is a part of company’s filings submitted to BSE.

Emcure Pharma Share Price

1678.50 36.90 (2.25%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×